NCT04601246

Brief Summary

This study will evaluate women's experiences with pain management and perceived attitudes regarding opioid use for postpartum pain management and examine differences by race/ ethnicity. Women will participate in in-depth qualitative interviews regarding their postpartum pain experience after a cesarean delivery. In this cohort, the investigators will evaluate how experiences of postpartum pain management and perceptions of provider attitudes vary across self-identified race/ethnicity. When applicable, mixed methods integration of patient-reported and clinical data from NNM2 will also allow exploration of patient factors contributing to such variation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2020

Completed
17 days until next milestone

First Posted

Study publicly available on registry

October 23, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

December 1, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2021

Completed
Last Updated

January 4, 2022

Status Verified

January 1, 2022

Enrollment Period

1 year

First QC Date

October 6, 2020

Last Update Submit

January 3, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Themes of pain management and perceived attitudes regarding opioid use for postpartum pain management

    Through analysis of qualitative interviews, themes such as satisfaction, engagement, respect, and preferences will be reviewed, and the constant comparative method will be applied.

    24-48 hours after delivery

  • Themes of pain management and perceived attitudes regarding opioid use for postpartum pain management

    Through analysis of qualitative interviews, themes such as satisfaction, engagement, respect, and preferences will be reviewed, and the constant comparative method will be applied.

    2-4 weeks after hospital discharge

  • Differences in postpartum pain experiences by maternal race/ethnicity

    Through analysis of qualitative interviews, we will evaluate how experiences of postpartum pain management and perceptions of provider attitudes vary across self-identified race/ethnicity.

    24-48 hours after delivery

  • Differences in postpartum pain experiences by maternal race/ethnicity

    Through analysis of qualitative interviews, we will evaluate how experiences of postpartum pain management and perceptions of provider attitudes vary across self-identified race/ethnicity.

    2-4 weeks after hospital discharge

Eligibility Criteria

Age16 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pregnant and postpartum women are the primary focus of this investigation.

You may qualify if:

  • Pregnant (any plurality) delivering at or after 20 weeks of gestation OR postpartum (during hospitalization), regardless of perinatal outcome
  • years or older
  • Low-income socioeconomic status (publicly funded prenatal care or uninsured)
  • Ability to speak and read English and/or Spanish
  • Planned or experienced cesarean delivery

You may not qualify if:

  • HIV (as these patients already receive intensive social support and navigation-like services)
  • Prior pregnancy in which individual declined participation
  • Recent COVID-19 positive test, unless patient is asymptomatic and can conduct the study visit via video conference
  • Contraindication to opioid or non-steroidal anti-inflammatory drugs
  • Non-opioid naïve (defined as ≥3 opioid prescriptions in the year prior to recruitment)
  • Use of general anesthesia for delivery
  • Postpartum intensive care unit admission
  • Known substance use disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northwestern Memorial Hospital

Chicago, Illinois, 60611, United States

Location

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Nevert Badreldin, MD

    Northwestern University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Obstetrics and Gynecology (Maternal Fetal Medicine)

Study Record Dates

First Submitted

October 6, 2020

First Posted

October 23, 2020

Study Start

December 1, 2020

Primary Completion

December 1, 2021

Study Completion

December 30, 2021

Last Updated

January 4, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations